Evidence map›Paper›PMID 41630900›Full record

ArticleiScience2026

A nuclear isoform of hydroxyacyl-COA dehydrogenase inhibits tumor progression in colorectal cancer.

Yunyi Gao, Lei Yu, Jingyu Hou, Yunguang Hong, Xiangwei Gao, Zhanghui Chen

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yunyi GaoZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, China.
Lei YuZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, China.
Jingyu HouSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Yunguang HongDepartment of Hematology, Central People's Hospital of Zhanjiang, Zhanjiang, China.
Xiangwei GaoSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Zhanghui ChenZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternate translation initiation expands protein diversity, which is adopted by cancers for progression. However, the majority of these alternative initiation events in cancers remain largely undefined. In this study, we demonstrate that the human hydroxyacyl-CoA dehydrogenase (HADH) gene, catalyzing the third step of the mitochondrial β-oxidation cascade, has two alternative translation start codons. The translation from the downstream start codon produces a short isoform (HADH-S) primarily localized in the nucleus. HADH-S is downregulated in colorectal cancer. Overexpression of HADH-S inhibits colorectal tumorigenesis

Indexed as

BiochemistryCancer

Identifiers

PMID41630900
PMCPMC12860641

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.